HanchorBio Inc. Sustainability Profile
HanchorBio Inc., a leading biotechnology firm headquartered in Taiwan (TW), has been at the forefront of innovative solutions since its establishment. Specialising in advanced biopharmaceuticals and cutting-edge research, the company operates primarily in the Asia-Pacific region, with a growing presence in global markets. Founded in 2015, HanchorBio has achieved significant milestones, including the development of unique therapeutic products that address unmet medical needs. Their core offerings, which include monoclonal antibodies and biologics, are distinguished by their precision and efficacy, setting new standards in the industry. With a strong commitment to research and development, HanchorBio has positioned itself as a key player in the biopharmaceutical landscape, recognised for its contributions to healthcare advancements and patient outcomes.
DitchCarbon Score
How does HanchorBio Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HanchorBio Inc.'s score of 20 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HanchorBio Inc.'s reported carbon emissions
HanchorBio Inc., headquartered in Taiwan (TW), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that HanchorBio Inc. may still be in the early stages of establishing its carbon footprint and climate commitments. In the context of the industry, many companies are increasingly adopting science-based targets and committing to net-zero emissions. However, without specific initiatives or targets from HanchorBio Inc., it remains unclear how the company plans to address its environmental impact or align with industry standards. As the company develops its sustainability strategy, it may consider setting measurable goals to enhance its climate commitments and contribute to global efforts in reducing greenhouse gas emissions.
How Carbon Intensive is HanchorBio Inc.'s Industry?
How Carbon Intensive is HanchorBio Inc.'s Location?
HanchorBio Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
HanchorBio Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
